---
title: "Cronos Group Inc. (CRON.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRON.US.md"
symbol: "CRON.US"
name: "Cronos Group Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-20T15:55:44.624Z"
locales:
  - [en](https://longbridge.com/en/quote/CRON.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRON.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRON.US.md)
---

# Cronos Group Inc. (CRON.US)

## Company Overview

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [ecronosgroup.com](https://ecronosgroup.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.48)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 70 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 28.05% |  |
| Net Profit YoY | -103.67% |  |
| P/B Ratio | 0.92 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 989323376.22 |  |
| Revenue | 159535000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -0.17% | D |
| Profit Margin | -1.14% | D |
| Gross Margin | 42.36% | B |
| Revenue YoY | 28.05% | A |
| Net Profit YoY | -103.67% | E |
| Total Assets YoY | 1.58% | C |
| Net Assets YoY | 0.81% | C |
| Cash Flow Margin | -2138.69% | E |
| OCF YoY | 28.05% | A |
| Turnover | 0.14 | E |
| Gearing Ratio | 4.12% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cronos Group Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "28.05%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-103.67%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.92",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "989323376.22",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "159535000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-0.17%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-1.14%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "42.36%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "28.05%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-103.67%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.58%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.81%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-2138.69%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "28.05%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.14",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "4.12%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -544.48 | 228/189 | 52.19 | 28.00 | 15.98 |
| PB | 0.92 | 46/189 | 0.94 | 0.90 | 0.76 |
| PS (TTM) | 6.20 | 106/189 | 7.64 | 7.15 | 6.40 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 75% |
| Hold | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.66 |
| Highest Target | 2.30 |
| Lowest Target | 2.30 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CRON.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CRON.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CRON.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CRON.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**